Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
36 tokens/sec
GPT-4o
12 tokens/sec
Gemini 2.5 Pro Pro
37 tokens/sec
o3 Pro
6 tokens/sec
GPT-4.1 Pro
4 tokens/sec
DeepSeek R1 via Azure Pro
33 tokens/sec
2000 character limit reached

Scaling methods for accelerating kinetic Monte Carlo simulations of chemical reaction networks (1903.08615v2)

Published 20 Mar 2019 in q-bio.QM, physics.chem-ph, and q-bio.MN

Abstract: Various kinetic Monte Carlo algorithms become inefficient when some of the population sizes in a system are large, which gives rise to a large number of reaction events per unit time. Here, we present a new acceleration algorithm based on adaptive and heterogeneous scaling of reaction rates and stoichiometric coefficients. The algorithm is conceptually related to the commonly used idea of accelerating a stochastic simulation by considering a sub-volume $\lambda \Omega$ ($0<\lambda<1$) within a system of interest, which reduces the number of reaction events per unit time occurring in a simulation by a factor $1/\lambda$ at the cost of greater error in unbiased estimates of first moments and biased overestimates of second moments. Our new approach offers two unique benefits. First, scaling is adaptive and heterogeneous, which eliminates the pitfall of overaggressive scaling. Second, there is no need for an \emph{a priori} classification of populations as discrete or continuous (as in a hybrid method), which is problematic when discreteness of a chemical species changes during a simulation. The method requires specification of only a single algorithmic parameter, $N_c$, a global critical population size above which populations are effectively scaled down to increase simulation efficiency. The method, which we term partial scaling, is implemented in the open-source BioNetGen software package. We demonstrate that partial scaling can significantly accelerate simulations without significant loss of accuracy for several published models of biological systems. These models characterize activation of the mitogen-activated protein kinase ERK, prion protein aggregation, and T-cell receptor signaling.

Summary

We haven't generated a summary for this paper yet.

Dice Question Streamline Icon: https://streamlinehq.com

Follow-up Questions

We haven't generated follow-up questions for this paper yet.